Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Gentiva Health Services (NASDAQ: GTIV ) lost over 10% of their value today after the company released an underwhelming earnings report this morning.
So what: Gentiva's third quarter revenue came in at $410.5 million, a 3% year-over-year decline and below the $415.1 million consensus. Wall Street was looking for earnings of $0.22 per share from Gentiva, which swung and missed with an EPS result of just $0.15. Looking forward, Gentiva now expects full-year revenue in the $1.72 billion to $1.74 billion range, which is better than the $1.68 billion consensus. However, its full-year EPS guidance range of $0.90 to $1.00 only hits Wall Street's $0.94 EPS expectation in the middle.
Now what: Gentiva's full-year revenue projection is barely a hair above the $1.68 billion trailing 12-month revenue that it had reported prior to this latest quarter, and the company continues to struggle with profitability on a GAAP basis. This report isn't particularly impressive, and the stock has been stuck in a rut for the past year after a big run-up in 2012. There might be a silver lining here, but you're going to have to dig pretty deep to find it.
Want more news and updates? Add Gentiva to your Watchlist now.
Will Obamacare help or hurt companies like Gentiva?
Obamacare seems complex, but it doesn't have to be. In only minutes, you can learn the critical facts you need to know in a special free report called Everything You Need to Know About Obamacare. But don't hesitate; because it's not often that we release a FREE guide containing this much information and money-making advice. Please click here to access your free copy.